{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:19:43Z","timestamp":1790972383149,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00277-010-1045-7","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T11:18:27Z","timestamp":1281957507000},"page":"173-183","source":"Crossref","is-referenced-by-count":29,"title":["Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia"],"prefix":"10.1007","volume":"90","author":[{"given":"Monika","family":"Podhorecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Halicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Kowal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Chocholska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dmoszynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,17]]},"reference":[{"key":"1045_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","volume":"17","author":"F Calligaris-Cappio","year":"1999","unstructured":"Calligaris-Cappio F, Hamblin TJ (1999) B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 17:399\u2013408","journal-title":"J Clin Oncol"},{"key":"1045_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0268-960X(97)90007-2","volume":"11","author":"TJ Hamblin","year":"1997","unstructured":"Hamblin TJ, Oscier DG (1997) Chronic lymphocytic leukemia: the nature of the leukemic cells. Blood Rev 11:119\u2013128","journal-title":"Blood Rev"},{"key":"1045_CR3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0021-9673(00)00211-9","volume":"881","author":"X Gu","year":"2000","unstructured":"Gu X, Chu Q, O\u2019Dwyer M, Zeece M (2000) Analysis of resveratrol in wine by capillary electrophoresis. J Chromatogr A 881:471\u2013481","journal-title":"J Chromatogr A"},{"key":"1045_CR4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood.V92.3.996","volume":"92","author":"MV Cl\u00e9ment","year":"1998","unstructured":"Cl\u00e9ment MV, Hirpara JL, Chawdhury SH, Pervaiz S (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92:996\u20131002","journal-title":"Blood"},{"key":"1045_CR5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1089\/152308601317203567","volume":"3","author":"KPL Bhat","year":"2001","unstructured":"Bhat KPL, Kosmeder JW, Pezzuto JM (2001) Biological effects of resveratrol. Antioxid Redox Signal 3:1041\u20131064","journal-title":"Antioxid Redox Signal"},{"key":"1045_CR6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1042\/BST0351156","volume":"35","author":"CA Lastra de la","year":"2007","unstructured":"de la Lastra CA, Villegas I (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35:1156\u20131160","journal-title":"Biochem Soc Trans"},{"key":"1045_CR7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4615-1283-7_13","volume":"492","author":"GJ Soleas","year":"2001","unstructured":"Soleas GJ, Diamandis EP, Goldberg DM (2001) The world of resveratrol. Adv Exp Med Biol 492:159\u2013182","journal-title":"Adv Exp Med Biol"},{"key":"1045_CR8","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/0140-6736(92)91277-F","volume":"8808","author":"S Renaud","year":"1992","unstructured":"Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 8808:1523\u20131526","journal-title":"Lancet"},{"key":"1045_CR9","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1089\/ars.2008.2412","volume":"11","author":"S Pervaiz","year":"2009","unstructured":"Pervaiz S, Holme AL (2009) Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 11:2851\u20131897","journal-title":"Antioxid Redox Signal"},{"key":"1045_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3940(01)01654-8","volume":"302","author":"G Nicolini","year":"2001","unstructured":"Nicolini G, Rigolio R, Miloso M, Bertelli AA, Tredici G (2001) Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line. Neurosci Lett 302:41\u201344","journal-title":"Neurosci Lett"},{"key":"1045_CR11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","volume":"275","author":"M Jang","year":"1997","unstructured":"Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218\u2013220","journal-title":"Science"},{"key":"1045_CR12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/cbt.3.1.683","volume":"3","author":"AR Jazirehi","year":"2004","unstructured":"Jazirehi AR, Bonavida B (2004) Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin\u2019s lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther 3:71\u201384","journal-title":"Mol Cancer Ther"},{"key":"1045_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1385\/1-59259-973-7:073","volume":"314","author":"X Huang","year":"2006","unstructured":"Huang X, Darzynkiewicz Z (2006) Cytometric assessment of histone H2AX phosphorylation: a reporter of DNA damage. Meth Mol Biol 314:73\u201380","journal-title":"Meth Mol Biol"},{"key":"1045_CR14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70:440\u2013446","journal-title":"Cancer Res"},{"key":"1045_CR15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.leu.2404477","volume":"21","author":"B Cate ten","year":"2007","unstructured":"ten Cate B, Samplonius DF, Bijma T, de Leij LF, Helfrich W, Bremer E (2007) The histone deacetylase inhibitor valproic acid potently augments gemtuzumab ozogamicin-induced apoptosis in acute myeloid leukemic cells. Leukemia 21:248\u2013252","journal-title":"Leukemia"},{"key":"1045_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2141.2008.07426.x","volume":"144","author":"AB Bouzar","year":"2009","unstructured":"Bouzar AB, Boxus M, Defoiche J, Berchem G, Macallan D, Pettengell R et al (2009) Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol 144:41\u201352","journal-title":"Br J Haematol"},{"key":"1045_CR17","first-page":"17","volume":"23","author":"MH Aziz","year":"2003","unstructured":"Aziz MH, Kumar R, Ahmad N (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms. Int J Oncol 23:17\u201328","journal-title":"Int J Oncol"},{"key":"1045_CR18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/carcin\/22.8.1111","volume":"22","author":"J Gusman","year":"2001","unstructured":"Gusman J, Malonne H, Atassi G (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22:1111\u20131117","journal-title":"Carcinogenesis"},{"key":"1045_CR19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-5793(97)01572-X","volume":"42","author":"M Fontecave","year":"1998","unstructured":"Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 42:277\u2013279","journal-title":"FEBS Lett"},{"key":"1045_CR20","first-page":"893","volume":"3","author":"AK Joe","year":"2002","unstructured":"Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB (2002) Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 3:893\u2013903","journal-title":"Clin Cancer Res"},{"key":"1045_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0027-5107(02)00330-5","volume":"523","author":"Z Dong","year":"2003","unstructured":"Dong Z (2003) Molecular mechanism of the chemopreventive effect of resveratrol. Mutat Res 523:145\u2013150","journal-title":"Mutat Res"},{"key":"1045_CR22","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1096\/fj.03-0168rev","volume":"17","author":"S Pervaiz","year":"2003","unstructured":"Pervaiz S (2003) Resveratrol: from grapevines to mammalian biology. FASEB J 17:1975\u20131985","journal-title":"FASEB J"},{"key":"1045_CR23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-2141.2002.03520.x","volume":"117","author":"V Roman","year":"2002","unstructured":"Roman V, Billard C, Kern C, Ferry-Dumazet H, Izard JC, Mohammad R et al (2002) Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br J Haematol 117:842\u2013851","journal-title":"Br J Haematol"},{"key":"1045_CR24","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1080\/1042819021000015952","volume":"43","author":"C Billard","year":"2002","unstructured":"Billard C, Izard JC, Roman V, Kern C, Mathiot C, Mentz F, Kolb JP (2002) Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Leuk Lymphoma 43:1991\u20132002","journal-title":"Leuk Lymphoma"},{"key":"1045_CR25","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2009-07-233718","volume":"114","author":"AV Kurtova","year":"2009","unstructured":"Kurtova AV, Balakrishnan K, Chen R, Ding W, Schnabl S, Quiroga MP, Sivina M, Wierda WG, Estrov Z, Keating MJ, Shehata M, J\u00e4ger U, Gandhi V, Kay NE, Plunkett W, Burger JA (2009) Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 114:4441\u20134450","journal-title":"Blood"},{"key":"1045_CR26","doi-asserted-by":"crossref","unstructured":"Shehata M, Schnabl S, Demirtas D, Hilgarth M, Hubmann R, Ponath E, Badrnya S, Lehner C, Hoelbl A, Duechler M, Gaiger A, Zielinski C, Schwarzmeier JD, Jaeger U (2010) Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K\/Akt cascade counteract the anti-apoptotic effect of human stromal cells in chronic lymphocytic leukemia. Blood. Epub ahead of print","DOI":"10.1182\/blood-2009-10-248054"},{"key":"1045_CR27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.leukres.2003.12.003","volume":"28","author":"C Quiney","year":"2004","unstructured":"Quiney C, Dauzonne D, Kern C, Fourneron JD, Izard JC, Mohammad RM, Kolb JP, Billard C (2004) Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells. Leuk Res 28:851\u2013861","journal-title":"Leuk Res"},{"key":"1045_CR28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.leukres.2003.08.017","volume":"28","author":"C Nabhan","year":"2004","unstructured":"Nabhan C, Gartenhaus RB, Tallman MS (2004) Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era. Leuk Res 28:429\u2013442","journal-title":"Leuk Res"},{"key":"1045_CR29","first-page":"1113","volume":"27","author":"E Neste Van den","year":"2005","unstructured":"Van den Neste E, Cardoen S, Offner F, Bontemps F (2005) Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine. Int J Oncol 27:1113\u20131124","journal-title":"Int J Oncol"},{"key":"1045_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.transci.2004.10.004","volume":"32","author":"T Robak","year":"2005","unstructured":"Robak T (2005) Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. Transfus Apher Sci 32:33\u201344","journal-title":"Transfus Apher Sci"},{"key":"1045_CR31","first-page":"1389","volume":"16","author":"A Kobylinska","year":"2006","unstructured":"Kobylinska A, Bednarek J, Blonski JZ, Hanausek M, Walaszek Z, Robak T (2006) In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and\/or mitoxantrone. Oncol Rep 16:1389\u20131395","journal-title":"Oncol Rep"},{"key":"1045_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3816\/CLM.2009.n.071","volume":"9","author":"VA Morrison","year":"2009","unstructured":"Morrison VA (2009) Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis. Clin Lymphoma Myeloma 9:365\u2013370","journal-title":"Clin Lymphoma Myeloma"},{"key":"1045_CR33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/sj\/leu\/2401368","volume":"13","author":"T Robak","year":"1999","unstructured":"Robak T, B\u0142o\u0144ski JZ, Urba\u0144ska-Ry\u015b H, B\u0142asi\u0144ska-Morawiec M, Skotnicki AB (1999) 2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55\u00a0years old and younger. Leukemia 13:518\u2013523","journal-title":"Leukemia"},{"key":"1045_CR34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.leukres.2008.09.023","volume":"33","author":"M Podhorecka","year":"2009","unstructured":"Podhorecka M, Halicka HD, Klimek P, Kowal M, Dmoszynska A (2009) Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures. Leuk Res 33:997\u20131000","journal-title":"Leuk Res"},{"key":"1045_CR35","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/leu.2009.98","volume":"23","author":"K Giannopoulos","year":"2009","unstructured":"Giannopoulos K, Dmoszynska A, Kowal M, Wasik-Szczepanek E, Bojarska-Junak A, Rolinski J et al (2009) Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide\/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia. Leukemia 23:1771\u20131778","journal-title":"Leukemia"},{"key":"1045_CR36","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1182\/blood-2005-02-0669","volume":"106","author":"AA Chanan-Khan","year":"2005","unstructured":"Chanan-Khan AA, Miller KC, Takeshita K, Koryzyna A, DonohueK BZP et al (2005) Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL). Blood 106:3348\u20133352","journal-title":"Blood"},{"key":"1045_CR37","first-page":"185","volume":"2","author":"S Stilgenbauer","year":"2006","unstructured":"Stilgenbauer S (2006) Chromic lymphocytic leukemia:genetics for predicting outcome. Hematology 2:185\u2013190","journal-title":"Hematology"},{"key":"1045_CR38","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","volume":"348","author":"M Crespo","year":"2003","unstructured":"Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348:1764\u20131775","journal-title":"N Engl J Med"},{"key":"1045_CR39","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848\u20131854","journal-title":"Blood"},{"key":"1045_CR40","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood.V89.11.4153","volume":"89","author":"DG Oscier","year":"1997","unstructured":"Oscier DG, Thompsett A, Zhu D, Stevenson FK (1997) Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 89:4153\u20134160","journal-title":"Blood"},{"key":"1045_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4274(02)00151-0","volume":"135","author":"R Salvia De","year":"2002","unstructured":"De Salvia R, Festa F, Ricordy R, Perticone P, Cozzi R (2002) Resveratrol affects in a different way primary versus fixed DNA damage induced by H(2)O(2) in mammalian cells in vitro. Toxicol Lett 135:1\u20139","journal-title":"Toxicol Lett"},{"key":"1045_CR42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1196\/annals.1299.067","volume":"1010","author":"KA Ahmad","year":"2003","unstructured":"Ahmad KA, Clement MV, Pervaiz S (2003) Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxide-induced apoptosis. Ann NY Acad Sci 1010:365\u2013373","journal-title":"Ann NY Acad Sci"},{"key":"1045_CR43","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.freeradbiomed.2006.09.007","volume":"4","author":"LF Zheng","year":"2006","unstructured":"Zheng LF, Wei QY, Cai YJ, Fang JG, Zhou B, Yang L et al (2006) DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: mechanism and structure-activity relationship. Free Radic Biol Med 4:1807\u20131816","journal-title":"Free Radic Biol Med"},{"key":"1045_CR44","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.febslet.2005.04.077","volume":"579","author":"AS Azmi","year":"2005","unstructured":"Azmi AS, Bhat SH, Hadi SM (2005) Resveratrol-Cu(II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties. FEBS Lett 579:3131\u20133135","journal-title":"FEBS Lett"},{"key":"1045_CR45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.febslet.2005.12.059","volume":"580","author":"AS Azmi","year":"2006","unstructured":"Azmi AS, Bhat SH, Hanif S, Hadi SM (2006) Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. FEBS Lett 580:533\u2013538","journal-title":"FEBS Lett"},{"key":"1045_CR46","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.4161\/cc.5.17.3191","volume":"17","author":"T Tanaka","year":"2006","unstructured":"Tanaka T, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z (2006) Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell Cycle 17:1940\u20131945","journal-title":"Cell Cycle"},{"key":"1045_CR47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/1-59259-973-7:081","volume":"314","author":"Z Darzynkiewicz","year":"2006","unstructured":"Darzynkiewicz Z, Huang X, Okafuji M (2006) Detection of DNA strand breaks by flow and laser scanning cytometry in studies of apoptosis and cell proliferation (DNA replication). Meth Mol Biol 314:81\u201393","journal-title":"Meth Mol Biol"},{"key":"1045_CR48","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/carcin\/bgi165","volume":"26","author":"A Tyagi","year":"2005","unstructured":"Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R (2005) Resveratrol causes Cdc2-tyr15 phosphorylation via ATM\/ATR-Chk1\/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26:1978\u20131987","journal-title":"Carcinogenesis"},{"key":"1045_CR49","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.mad.2009.06.005","volume":"130","author":"M Rusin","year":"2009","unstructured":"Rusin M, Zajkowicz A, Butkiewicz D (2009) Resveratrol induces senescence\u2013like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1. Mech Ageing Dev 130:528\u2013537","journal-title":"Mech Ageing Dev"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00277-010-1045-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T14:51:04Z","timestamp":1591800664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-010-1045-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,17]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1007\/s00277-010-1045-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,17]]}}}